Physician

Keshav Panday, MD

According to 2025 Medicare claims, Keshav Panday, MD (NPI: 1710171194) practices rheumatology in the Oklahoma City, OK market, with the plurality of this provider's patient population coming from Oklahoma, OK. This provider's primary affiliated billing organization is OKLAHOMA ARTHRITIS CENTER, P.C. (NPI: 1528036019; TIN: 731578116) and primary practice location at 73013-3084.

Panday's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 769 traditional Medicare patients, billed 243,520 HCPCS/CPT codes, and received $3,029,251 in Medicare payments. The top billing code was 96375 (Injection of additional new drug or substance into vein). Part D data shows 3,612 prescription claims across 341 beneficiaries totaling $3,185,382 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 7 records totaling $446. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $9,581 and ending at $3,029,251. Concurrently, Part D prescription costs have risen steadily, from $17,740 to $3,185,382. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.9M$5.8M2015 Medicare payment: $9,581 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $40,227 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $50,646 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,734,663 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $5,828,875 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,267,011 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,951,051 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,652,840 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,448,082 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,029,251 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201551111$9,581
2016185559$40,227
20172301,114$50,646
2018858167,950$3,734,663
20191,032290,825$5,828,875
2020761118,443$2,267,011
2021748195,051$2,951,051
2022717157,198$2,652,840
2023816244,416$3,448,082
2024769243,520$3,029,251

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.6M$3.2M2015 Drug cost: $17,740 (USD; Tot_Drug_Cst)2016 Drug cost: $184,181 (USD; Tot_Drug_Cst)2017 Drug cost: $590,694 (USD; Tot_Drug_Cst)2018 Drug cost: $363,835 (USD; Tot_Drug_Cst)2019 Drug cost: $739,602 (USD; Tot_Drug_Cst)2020 Drug cost: $879,582 (USD; Tot_Drug_Cst)2021 Drug cost: $1,154,086 (USD; Tot_Drug_Cst)2022 Drug cost: $1,475,520 (USD; Tot_Drug_Cst)2023 Drug cost: $1,924,580 (USD; Tot_Drug_Cst)2024 Drug cost: $3,185,382 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201543210$17,740
2016137929$184,181
20171811,664$590,694
20182361,217$363,835
20192191,393$739,602
20202942,079$879,582
20212772,389$1,154,086
20223072,799$1,475,520
20233012,958$1,924,580
20243413,612$3,185,382

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
96375Injection of additional new drug or substance into vein3881,335$10
80053Blood test, comprehensive group of blood chemicals357591$10
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count352587$7
86140Measurement c-reactive protein for detection of infection or inflammation351581$5
85652Red blood cell sedimentation rate, to detect inflammation, automated347574$3

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab802,350$625,014
Enbrel SureclickEtanercept711,998$522,018
RinvoqUpadacitinib331,170$240,751
TremfyaGuselkumab13700$208,919
Cosentyx Sensoready PenSecukinumab11511$160,565

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.7$446Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Keshav Panday, MD?

Tedicare shows public-source Medicare data for Keshav Panday, MD (NPI 1710171194), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Keshav Panday, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Keshav Panday, MD?

Keshav Panday, MD is linked to OKLAHOMA ARTHRITIS CENTER, P.C. (billing NPI 1528036019) in the available physician profile data.

Does Keshav Panday, MD have Open Payments data?

Keshav Panday, MD has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.